elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26862544-10625124-D236-4A96-A3D7-8D394F8FD545
Q26862544-10625124-D236-4A96-A3D7-8D394F8FD545
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26862544-10625124-D236-4A96-A3D7-8D394F8FD545
PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms
P2860
Q26862544-10625124-D236-4A96-A3D7-8D394F8FD545
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26862544-10625124-D236-4A96-A3D7-8D394F8FD545
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a01628d6233d3f3a94c96f9f50490db5094cd48
P2860
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.